Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Clinical trial NCT04445285 · RECRUITING
Trial details
- NCT number
- NCT04445285
- Sponsor
- Jon Simmons
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-28
- Primary completion
- 2021-11-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.